End-of-day quote
Shanghai S.E.
18:00:00 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
7.48
CNY
|
-6.27%
|
|
-4.59%
|
-10.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,478
|
8,434
|
11,651
|
9,391
|
6,741
|
6,013
|
-
|
-
|
Enterprise Value (EV)
1 |
7,172
|
8,170
|
11,882
|
9,974
|
7,710
|
7,243
|
7,349
|
7,455
|
P/E ratio
|
35.9
x
|
36.8
x
|
46.1
x
|
37.1
x
|
26.3
x
|
20.7
x
|
15.9
x
|
15.6
x
|
Yield
|
0.84%
|
0.82%
|
0.65%
|
0.95%
|
1.33%
|
1.7%
|
2.18%
|
2.33%
|
Capitalization / Revenue
|
6.75
x
|
5.76
x
|
5.26
x
|
3.87
x
|
2.54
x
|
2.04
x
|
1.69
x
|
1.58
x
|
EV / Revenue
|
6.48
x
|
5.58
x
|
5.36
x
|
4.11
x
|
2.9
x
|
2.45
x
|
2.06
x
|
1.96
x
|
EV / EBITDA
|
22.5
x
|
20.6
x
|
23.5
x
|
17.2
x
|
14.3
x
|
10.4
x
|
9.81
x
|
8.14
x
|
EV / FCF
|
-75,573,414
x
|
-
|
1,211,420,562
x
|
-174,767,170
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
5.95
x
|
6.13
x
|
7.38
x
|
5.29
x
|
3.53
x
|
2.85
x
|
2.46
x
|
2.28
x
|
Nbr of stocks (in thousands)
|
796,858
|
796,858
|
796,858
|
800,819
|
802,532
|
803,929
|
-
|
-
|
Reference price
2 |
9.385
|
10.58
|
14.62
|
11.73
|
8.400
|
7.480
|
7.480
|
7.480
|
Announcement Date
|
20-01-21
|
21-01-18
|
22-01-11
|
23-01-15
|
24-01-16
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,107
|
1,465
|
2,217
|
2,428
|
2,659
|
2,954
|
3,567
|
3,813
|
EBITDA
1 |
319.3
|
395.7
|
504.6
|
580.9
|
539.5
|
697.7
|
748.8
|
916.1
|
EBIT
1 |
262.3
|
307
|
389.5
|
348.2
|
384.6
|
456.7
|
558.3
|
604.8
|
Operating Margin
|
23.69%
|
20.96%
|
17.57%
|
14.34%
|
14.47%
|
15.46%
|
15.65%
|
15.86%
|
Earnings before Tax (EBT)
1 |
273
|
322
|
400.1
|
371.2
|
398.5
|
445.7
|
571.3
|
572.8
|
Net income
1 |
208.4
|
229.3
|
252.7
|
252.9
|
255.5
|
287.9
|
381.4
|
369.9
|
Net margin
|
18.82%
|
15.65%
|
11.4%
|
10.42%
|
9.61%
|
9.74%
|
10.69%
|
9.7%
|
EPS
2 |
0.2615
|
0.2877
|
0.3171
|
0.3157
|
0.3188
|
0.3617
|
0.4694
|
0.4785
|
Free Cash Flow
|
-94.9
|
-
|
9.808
|
-57.07
|
-
|
-
|
-
|
-
|
FCF margin
|
-8.57%
|
-
|
0.44%
|
-2.35%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
1.94%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
3.88%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0785
|
0.0871
|
0.0954
|
0.1109
|
0.1120
|
0.1272
|
0.1628
|
0.1740
|
Announcement Date
|
20-01-21
|
21-01-18
|
22-01-11
|
23-01-15
|
24-01-16
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
454.2
|
408.4
|
475.6
|
603.6
|
940
|
468.4
|
536.1
|
595.2
|
1,059
|
458.6
|
1,043
|
745
|
736.8
|
512.9
|
1,197
|
EBITDA
1 |
-
|
-
|
73.32
|
130.4
|
-
|
-
|
-
|
-
|
-
|
-
|
227.6
|
179.2
|
278.7
|
149.7
|
262.8
|
EBIT
1 |
-
|
-36.12
|
56.16
|
83.66
|
244.5
|
-32.01
|
63.77
|
57.15
|
295.7
|
-30.03
|
169.4
|
121
|
220.5
|
84.84
|
198
|
Operating Margin
|
-
|
-8.84%
|
11.81%
|
13.86%
|
26.01%
|
-6.83%
|
11.89%
|
9.6%
|
27.93%
|
-6.55%
|
16.24%
|
16.24%
|
29.93%
|
16.54%
|
16.54%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.1478
|
-0.0352
|
0.0628
|
0.0818
|
0.2196
|
-0.0301
|
0.0649
|
0.0600
|
0.2300
|
-0.0340
|
0.1272
|
0.0908
|
0.1793
|
0.0642
|
0.1497
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1272
|
-
|
-
|
Announcement Date
|
19-07-10
|
22-04-27
|
22-08-25
|
22-10-25
|
23-01-15
|
23-04-27
|
23-08-30
|
23-10-30
|
24-01-16
|
24-04-29
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
231
|
583
|
969
|
1,229
|
1,335
|
1,441
|
Net Cash position
1 |
306
|
265
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.4579
x
|
1.004
x
|
1.796
x
|
1.762
x
|
1.784
x
|
1.573
x
|
Free Cash Flow
|
-94.9
|
-
|
9.81
|
-57.1
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
16.5%
|
17.1%
|
17.2%
|
15.2%
|
13.9%
|
13.8%
|
15.8%
|
14.9%
|
ROA (Net income/ Total Assets)
|
11.9%
|
10.7%
|
8.09%
|
9.03%
|
5.43%
|
6.6%
|
7.4%
|
-
|
Assets
1 |
1,755
|
2,140
|
3,122
|
2,800
|
4,710
|
4,362
|
5,154
|
-
|
Book Value Per Share
2 |
1.580
|
1.730
|
1.980
|
2.220
|
2.380
|
2.620
|
3.030
|
3.270
|
Cash Flow per Share
2 |
0.2500
|
0.4300
|
0.4900
|
0.3400
|
0.3600
|
0.5800
|
0.6700
|
0.7600
|
Capex
1 |
297
|
347
|
378
|
333
|
408
|
333
|
368
|
436
|
Capex / Sales
|
26.82%
|
23.68%
|
17.07%
|
13.73%
|
15.35%
|
11.27%
|
10.32%
|
11.44%
|
Announcement Date
|
20-01-21
|
21-01-18
|
22-01-11
|
23-01-15
|
24-01-16
|
-
|
-
|
-
|
Last Close Price
7.48
CNY Average target price
12.21
CNY Spread / Average Target +63.24% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.95% | 831M | | 0.00% | 7.08B | | -11.41% | 2.91B | | -6.89% | 2.85B | | -27.64% | 1.83B | | -2.47% | 1.16B | | -6.63% | 1.07B | | +0.83% | 767M | | -9.85% | 747M | | -19.31% | 719M |
Testing Laboratories
|